1. Home
  2. UTHR vs TYL Comparison

UTHR vs TYL Comparison

Compare UTHR & TYL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo United Therapeutics Corporation

UTHR

United Therapeutics Corporation

HOLD

Current Price

$485.36

Market Cap

20.5B

Sector

Health Care

ML Signal

HOLD

Logo Tyler Technologies Inc.

TYL

Tyler Technologies Inc.

HOLD

Current Price

$348.35

Market Cap

19.1B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
UTHR
TYL
Founded
1996
1966
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
20.5B
19.1B
IPO Year
1999
N/A

Fundamental Metrics

Financial Performance
Metric
UTHR
TYL
Price
$485.36
$348.35
Analyst Decision
Buy
Buy
Analyst Count
12
13
Target Price
$498.83
$616.46
AVG Volume (30 Days)
343.7K
560.6K
Earning Date
02-25-2026
02-11-2026
Dividend Yield
N/A
N/A
EPS Growth
16.08
31.32
EPS
26.38
7.19
Revenue
$3,128,400,000.00
$2,298,292,000.00
Revenue This Year
$13.57
$10.86
Revenue Next Year
$5.72
$8.86
P/E Ratio
$18.16
$47.40
Revenue Growth
13.50
10.62
52 Week Low
$266.98
$320.23
52 Week High
$519.99
$661.31

Technical Indicators

Market Signals
Indicator
UTHR
TYL
Relative Strength Index (RSI) 54.06 22.44
Support Level $462.02 $320.23
Resistance Level $487.50 $355.80
Average True Range (ATR) 9.08 17.33
MACD 1.70 -8.63
Stochastic Oscillator 88.42 17.42

Price Performance

Historical Comparison
UTHR
TYL

About UTHR United Therapeutics Corporation

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. In addition, it is developing a pipeline of projects that includes new indications and delivery devices for existing products and new products to treat PAH and other conditions.

About TYL Tyler Technologies Inc.

Tyler Technologies provides a full suite of software solutions and services that address the needs of cities, counties, schools, courts and other local government entities. The company's three core products are Munis, which is the core ERP system, Odyssey, which is the court management system, or CMS, and payments. The company also provides a variety of add-on modules and offers outsourced property tax assessment services.

Share on Social Networks: